Cargando…

IDF21-0532 Hyponatremia severity affects patient outcome in COVID-19 infection

Detalles Bibliográficos
Autores principales:	Bogdanovic, J., Babic, I., Adzic Vukicevic, T., Lalic, K., Popovic, D., Lalic, N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Scientific Publishers 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164588/ http://dx.doi.org/10.1016/j.diabres.2022.109373

Ejemplares similares

IDF21-0524 Inhospital sodium variability associated with poor outcome in COVID-19 infection
por: Babic, I., et al.
Publicado: (2022)

IDF21-0236 Prevalence of Breakthrough Covid Infections and Its Severity among Vaccinated Individuals
por: Kesavadev, J., et al.
Publicado: (2022)

The Inflammatory and Hemostatic Cardiovascular Risk Markers During Acute Hyperglycemic Crisis in Type 1 and Type 2 Diabetes
por: Popovic, Dragana, et al.
Publicado: (2019)

Impact of acute hyperglycemia on layer-specific left ventricular strain in asymptomatic diabetic patients: an analysis based on two-dimensional speckle tracking echocardiography
por: Bogdanović, Jelena, et al.
Publicado: (2019)

IDF21-0690 Diabetics hospitalized for covid infection under corticosteroid therapy, what is the particularity?
por: Yousra, L., et al.
Publicado: (2022)

P05.32. A tool for rapid identification of potential herbal medicine-drug interactions 2011 update: a review
por: Girard, L, et al.
Publicado: (2012)

IDF21-0411 Correlation of Chest CT severity score with blood glucose levels in patients with COVID-19
por: Inamdar, A., et al.
Publicado: (2022)

IDF21-0377 Evaluation of the glycemic profile during 6 months after hospital discharge of patients with severe COVID-19
por: Lima, M., et al.
Publicado: (2022)

IDF21-0367 Descriptive study of infection by SARS-COV-2 in adults with Diabetes Mellitus
por: Russo, M.P., et al.
Publicado: (2022)

IDF21-0190 Maternal and perinatal outcomes during the COVID-19 epidemic in pregnancies complicated by gestational diabetes
por: Munda, A., et al.
Publicado: (2022)

IDF21-0444 Association Between Prior Antidiabetic Therapy and Outcome in Hospitalized COVID-19 Diabetic Subjects
por: Baidya, A., et al.
Publicado: (2022)

IDF21-0370 New forms of diabetic education during the COVID-19 pandemic
por: Bukovská, A.
Publicado: (2022)

IDF21-0331 Diabetes care to Palestine Refugees during COVID 19 pandemic
por: Shahin, Y.
Publicado: (2022)

IDF21-0539 Can the asymptomatic COVID-19 trigger the development of diabetes mellitus?
por: Jashi, L., et al.
Publicado: (2022)

IDF21-0320 Mortality and severity among Covid-19 patients who already vaccinated with inactivated Covid-19 vaccine
por: Tanod, D.V., et al.
Publicado: (2022)

IDF21-0097 Concomitant COVID-19 Infection and Ketosis Prone Diabetes. Coincidence or Relationship? A Case Report
por: Gonzalez, L., et al.
Publicado: (2022)

IDF21-0422 Two Anniversaries, Two Pandemics, Two Histories
por: Dapice, A.
Publicado: (2022)

mTOR Inhibitor Therapy and Metabolic Consequences: Where Do We Stand?
por: Kezic, Aleksandra, et al.
Publicado: (2018)

IDF21-0109 Coagulation Disorders in Type 2 Diabetes Mellitus Patients with COVID-19
por: Syukur, C., et al.
Publicado: (2022)

IDF21-0274 Impact of COVID-19 on Glycemic control in children with T1D in Kuwait
por: Aljuailla, F., et al.
Publicado: (2022)

IDF21-0583 Eye and COVID-19: A Systematic Literature Review and Bibliometric Analysis
por: Forouhari, A., et al.
Publicado: (2022)

Development and Validation of an HPLC Method for Simultaneous Determination of Capsaicinoids and Camphor in Over-the-Counter Medication for Topical Use
por: Lalić, Martin, et al.
Publicado: (2022)

IDF21-0683 Social and emotional impact of the COVID-19 pandemic in people with Type 1 Diabetes
por: Rodriguez Montalvan, B.F., et al.
Publicado: (2022)

IDF21-0557 Factors affecting Covid-19 Vaccine Attitude: Results from People Living with Chronic Conditions in Ibadan, Nigeria
por: Ojewale, L., et al.
Publicado: (2022)

IDF21-0499 How has the COVID-19 pandemic affected psychosocial health in people with diabetes? A one-year follow-up study
por: Olesen, K., et al.
Publicado: (2022)

IDF21-0663 Health-Related Quality of Life in Moroccan patients with diabetes after hospitalization for COVID-19
por: Azizi, A., et al.
Publicado: (2022)

IDF21-0234 The Virtual COVID In-patient (VCIP) Care and Post Covid Symptoms: a Comparison with Conventional Care
por: Kesavadev, J., et al.
Publicado: (2022)

IDF21-0273 New-Onset Diabetic Ketoacidosis as a first manifestation of Covid-19 at emergency department
por: Dhokar, R., et al.
Publicado: (2022)

Covid-19 As Occupational Disease in Healthcare Workers: a Brief Review of Cases in The Clinical Hospital Centre Rijeka, Croatia
por: Lalić, Hrvoje
Publicado: (2021)

IDF21-0123 Impact of Pre-existing Oral Antidiabetic Treatment on Clinical Outcomes of COVID-19: a Retrospective Study
por: Navale, A., et al.
Publicado: (2022)

IDF21-0616 Observational study on covid 19 and type 1 diabetes in the Chronic Care Center Lebanon
por: Maalouf Nawfal, P., et al.
Publicado: (2022)

IDF21-0593 COVID-19 hospitalizations and cardio-cerebrovascular complications at three months in people with diabetes
por: Iommi, M., et al.
Publicado: (2022)

IDF21-0533 Diabetes Mellitus in hospitalized COVID-19 patients – a retrospective cohort study
por: Çerma, A., et al.
Publicado: (2022)

IDF21-0090 Structure of mortality among patients with diabetes mellitus in the republic of Uzbekistan during COVID-19 pandemia
por: Tojieva, I., et al.
Publicado: (2022)

IDF21-0168 Pathway to Clinical Diabetes Services in COVID-19 Era: What Has Changed and What Are the Implications?
por: Adwubi, E., et al.
Publicado: (2022)

PSYCOGENIC POLYDIPSIA AND SEVERE HYPONATREMIA IN BIPOLAR AFFECTIVE DISORDER
por: Juan Felipe, Benítez-Mejía, et al.
Publicado: (2021)

IDF21-0496 Action Taken in the Kingdom of Bahrain for People with Diabetes (Preparedness and Response)
por: Al Hajeri, M.E.
Publicado: (2022)

IDF21-0463 Type 1 Diabetes with insulin resistance following SARS-CoV-2 infection
por: Veríssimo, D., et al.
Publicado: (2022)

IDF21-0567 Analysis of mortality and cardio-metabolic comorbidities in Covid-19 patients from Eastern European region
por: Popescu, I., et al.
Publicado: (2022)

IDF21-0220 Hypertension as a Prognostic Factor in the Prediction of Mortality in Patients with COVID-19: A Meta-Analysis
por: Juangco, J.R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uudkbekq786ofopchpnagl38vu